Results 241 to 250 of about 117,497 (280)

BRD9 at the crossroads of splicing, chromatin remodeling, and hematopoiesis. [PDF]

open access: yesProc Jpn Acad Ser B Phys Biol Sci
Yamasaki T, Nishimura K, Inoue D.
europepmc   +1 more source

A case of T-prolymphocytic leukemia harboring RAS mutation. [PDF]

open access: yesAnn Hematol
Perrone S   +9 more
europepmc   +1 more source

Clinical characteristics, management, and hematopoietic cell transplantation of patients with TLR8 gain-of-function. [PDF]

open access: yesBlood Adv
Arnold DE   +23 more
europepmc   +1 more source

Suppressing crucial oncogenes of leukemia initiator cells by major royal jelly protein 2 for mediating apoptosis in myeloid and lymphoid leukemia cells.

Food & Function, 2022
Relapse of leukemia and drug resistance are still the major obstacles to therapy due to leukemia-initiating stem/progenitor cells (LICs); thus, targeting them using safe compounds is crucial. Here, we evaluated the anti-leukemic effect of royal jelly (RJ)
Marwa M. Abu‐Serie, Noha H. Habashy
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy